Bristol Myers Squibb BMY
NYSE BMY
$62.93 -0.50 (-0.79%)
At close: Nov 16, 2026 · 4:00 PM EST

Bristol Myers Squibb (BMY) Return on Sales [ROS] (2009 - 2026)

Updated

Bristol Myers Squibb (BMY) reported Return on Sales [ROS] of 19.40% for Q3 2026, down 6.07 percentage points from 25.48% a year earlier and down 12.09 percentage points from the prior quarter.

Analysis

Bristol Myers Squibb (BMY) Return on Sales [ROS] (2009 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, Bristol Myers Squibb's Return on Sales [ROS] came in at 22.65%, up 5.92 percentage points year-over-year; for FY2025, it was 19.36%, up 36.70 percentage points from FY2024.

  • Return on Sales [ROS] has a five-year change of +35.52 percentage points (FY2020 to FY2025).
  • By year, Return on Sales [ROS] came in at -17.35% in FY2024 (-36.10 pp), 18.75% in FY2023 (+2.04 pp), 16.71% in FY2022 (-0.75 pp) and 17.46% in FY2021 (+33.62 pp).
  • Five-year quarterly Return on Sales [ROS] spans a low of -97.06% in Q1 2024 and a high of 31.50% in Q2 2026.
  • Year over year, Return on Sales [ROS] gained in six of the last eight quarters, with an average year-over-year change of +18.59 percentage points.
  • The high point for year-over-year Return on Sales [ROS] in five years was Q1 2025 (a gain of 123.58 percentage points); the low point was Q1 2024 (a drop of 121.49 percentage points).
  • Per Business Quant data, the three quarters before Q3 2026 came in at 31.50% (Q2 2026), 28.19% (Q1 2026) and 11.76% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 24.35%
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 36.01%
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 30.74%
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 29.12%
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 35.79%
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 41.71%
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 32.98%
10 Bristol Myers Squibb 128.63 Bn 83.82 Bn 8.92 Bn 19.40%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 19.40%
Jun 30, 2026 31.50%
Mar 31, 2026 28.19%
Dec 31, 2025 11.76%
Sep 30, 2025 25.48%
Jun 30, 2025 14.45%
Mar 31, 2025 26.52%
Dec 31, 2024 1.42%
Sep 30, 2024 14.09%
Jun 30, 2024 10.54%
Mar 31, 2024 -97.06%
Dec 31, 2023 14.59%
Sep 30, 2023 19.49%
Jun 30, 2023 16.56%
Mar 31, 2023 24.43%
Dec 31, 2022 16.30%
Sep 30, 2022 19.69%
Jun 30, 2022 16.47%
Mar 31, 2022 14.48%
Dec 31, 2021 15.50%
API Access

Bristol Myers Squibb Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=BMY&period=max&api_key=YOUR_API_KEY